Tilray Brands, Inc.

NasdaqGS:TLRY 株式レポート

時価総額:US$1.6b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Tilray Brands 過去の業績

過去 基準チェック /06

Tilray Brandsの収益は年間平均-54.4%の割合で減少していますが、 Pharmaceuticals業界の収益は年間 減少しています。収益は年間0.4% 21.1%割合で 増加しています。

主要情報

-54.4%

収益成長率

-34.9%

EPS成長率

Pharmaceuticals 業界の成長6.0%
収益成長率21.1%
株主資本利益率-9.8%
ネット・マージン-47.4%
前回の決算情報29 Feb 2024

最近の業績更新

Recent updates

Tilray Should Be Cut From Your Portfolio

Jul 14

Why Bears Think Tilray Brands Will Continue To Dip

May 29

Tilray Takes A Step Forward

May 21

An Intrinsic Calculation For Tilray Brands, Inc. (NASDAQ:TLRY) Suggests It's 34% Undervalued

May 01
An Intrinsic Calculation For Tilray Brands, Inc. (NASDAQ:TLRY) Suggests It's 34% Undervalued

Tilray Could Break Down

Apr 07

Tilray Brands, Inc.'s (NASDAQ:TLRY) Shares Climb 31% But Its Business Is Yet to Catch Up

Mar 27
Tilray Brands, Inc.'s (NASDAQ:TLRY) Shares Climb 31% But Its Business Is Yet to Catch Up

Tilray: Big Opportunities Ahead In Germany And Alcohol Segment

Mar 12

Tilray Brands (NASDAQ:TLRY) Is Carrying A Fair Bit Of Debt

Jan 25
Tilray Brands (NASDAQ:TLRY) Is Carrying A Fair Bit Of Debt

Tilray Remains Stuck In Neutral

Jan 10

Tilray Brands, Inc.'s (NASDAQ:TLRY) Price Is Right But Growth Is Lacking

Dec 19
Tilray Brands, Inc.'s (NASDAQ:TLRY) Price Is Right But Growth Is Lacking

Industry Analysts Just Upgraded Their Tilray Brands, Inc. (NASDAQ:TLRY) Revenue Forecasts By 13%

Oct 10
Industry Analysts Just Upgraded Their Tilray Brands, Inc. (NASDAQ:TLRY) Revenue Forecasts By 13%

Analysts Are Upgrading Tilray Brands, Inc. (NASDAQ:TLRY) After Its Latest Results

Oct 06
Analysts Are Upgrading Tilray Brands, Inc. (NASDAQ:TLRY) After Its Latest Results

Tilray Brands, Inc. (NASDAQ:TLRY) Shares Could Be 22% Below Their Intrinsic Value Estimate

Sep 18
Tilray Brands, Inc. (NASDAQ:TLRY) Shares Could Be 22% Below Their Intrinsic Value Estimate

Little Excitement Around Tilray Brands, Inc.'s (NASDAQ:TLRY) Revenues

Apr 17
Little Excitement Around Tilray Brands, Inc.'s (NASDAQ:TLRY) Revenues

An Intrinsic Calculation For Tilray Brands, Inc. (NASDAQ:TLRY) Suggests It's 28% Undervalued

Feb 03
An Intrinsic Calculation For Tilray Brands, Inc. (NASDAQ:TLRY) Suggests It's 28% Undervalued

収支内訳

Tilray Brands の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

NasdaqGS:TLRY 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
29 Feb 24743-3522420
30 Nov 23700-1,4302330
31 Aug 23651-1,4432291
31 May 23627-1,4532311
28 Feb 23596-1,7922281
30 Nov 22603-5782341
31 Aug 22614-5012281
31 May 22628-4772332
28 Feb 22617422172
30 Nov 21589-2751932
31 Aug 21564-3751811
31 May 21513-3671561
28 Feb 21468-5211431
30 Nov 20462-2431441
31 Aug 20426-1491382
31 May 20405-1031282
29 Feb 20387221172
30 Nov 19338-631191
31 Aug 19263-161051
31 May 19179-25971
28 Feb 1992-28801
30 Nov 184363551
31 Aug 183427441
31 May 182823340
28 Feb 182425220
30 Nov 172018160
31 Aug 171815140
31 May 17153100
28 Feb 1713690
30 Nov 1611270
31 Aug 169160
31 May 166050
29 Feb 165-140
30 Nov 153-330
31 Aug 151-430
31 May 150-530
28 Feb 150-530
30 Nov 140-330
31 Aug 140-320

質の高い収益: TLRYは現在利益が出ていません。

利益率の向上: TLRYは現在利益が出ていません。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: TLRYは利益が出ておらず、過去 5 年間で損失は年間54.4%の割合で増加しています。

成長の加速: TLRYの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: TLRYは利益が出ていないため、過去 1 年間の収益成長をPharmaceuticals業界 ( 19.9% ) と比較することは困難です。


株主資本利益率

高いROE: TLRYは現在利益が出ていないため、自己資本利益率 ( -9.78% ) はマイナスです。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘